How Much Did Accelus Raise?
Funding & Key Investors

Accelus has solidified its position in the medical device sector by securing a total of $32M in cumulative financing. This latest capital injection, totaling $0, underscores the market confidence in the firm's proprietary spinal implant technology. As the company transitions through its current growth phase, this infusion of resources serves as a critical catalyst for scaling its operational footprint and accelerating the deployment of its advanced surgical solutions across global markets.

The strategic backing reflects a broader trend of institutional interest in high-growth orthopedic technologies that promise to redefine standard surgical procedures. By leveraging this recent investment, Accelus is well-positioned to enhance its research and development capabilities, ensuring that its portfolio of spinal solutions remains at the forefront of clinical innovation.

What is Accelus?

Accelus
ManufacturingMedical Devices & Equipment

Accelus operates as a worldwide leader in expandable spinal implant technology, focusing on the development of Adaptive Geometry solutions. The company is dedicated to improving surgical precision and patient outcomes through a specialized suite of products designed for transforaminal lumbar interbody fusion (TLIF), posterior lumbar interbody fusion (PLIF), and endoscopic-assisted, percutaneous, and lateral spine surgeries. By integrating advanced engineering with clinical requirements, Accelus addresses the complex needs of modern spine surgeons, effectively bridging the gap between traditional surgical methods and next-generation minimally invasive techniques.

How much funding has Accelus raised?

Accelus has raised a total of $32M across 2 funding rounds:

2022

Series D

$12M

2024

Debt

$20M

Series D (2022): $12M with participation from Concord Health Partners

Debt (2024): $20M led by Symbiotic Capital

Key Investors in Accelus

Symbiotic Capital

A private investment firm focused on providing strategic debt and growth capital to companies within the healthcare and life sciences sectors.

Concord Health Partners

A healthcare-focused investment firm that targets business combinations and strategic growth opportunities within the medical technology and services landscape.

What's next for Accelus?

With the recent capital secured, Accelus is expected to prioritize the expansion of its commercial infrastructure and the continued refinement of its Adaptive Geometry platform. The company's roadmap likely includes scaling its sales force to capture a larger share of the lumbar fusion market and investing in clinical studies to validate the long-term efficacy of its implant systems. As the firm moves toward broader market penetration, the focus will remain on maintaining its competitive edge through technological differentiation and strategic partnerships within the healthcare ecosystem. This enterprise-level funding provides the necessary runway to navigate the regulatory and operational complexities inherent in the medical device industry while driving sustainable long-term value.

See full Accelus company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingPharmaceuticalsBusiness ServicesResearch & Development
Building MaterialsManufacturingArchitecture, Engineering & DesignConstruction ManagementConstruction
Automotive PartsManufacturingAutomobile Parts StoresRetail
ManufacturingMedical Devices & EquipmentDrug Stores & PharmaciesRetail

Frequently Asked Questions Regarding Accelus Financial Insights

What are the most recent funding rounds that Accelus has completed, and what were the funding rounds?
Accelus has recently completed 2 funding rounds: Debt on Jan 18, 2024, Series D on Jul 12, 2022.
What is the total amount of funding Accelus has raised to date?
Accelus has raised a total of $32M in funding to date.
How many funding rounds has Accelus completed?
Accelus has completed 2 funding rounds.
How much funding did Accelus raise in its most recent funding round?
Accelus raised $20M in its most recent funding round.
Who are the lead investors in Accelus's latest funding round?
The lead investor in Accelus's latest funding round was Symbiotic Capital. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Accelus's history?
The largest funding round in Accelus's history was $20M.
See more information about Accelus